U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Amoxicillin Powder, For Suspension
Status: Currently in Shortage
»Date first posted: 10/28/2022
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Aurobindo Pharma USA (Reverified 01/15/2024)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-01) On allocation. Demand increase for the drug
Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-01) On allocation. Demand increase for the drug
Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-01) On allocation. Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-01) On allocation. Demand increase for the drug
Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-55) On allocation. Demand increase for the drug
Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-80) On allocation. Demand increase for the drug
Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-50) On allocation. Demand increase for the drug
Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-75) On allocation. Demand increase for the drug
Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-55) On allocation. Demand increase for the drug
Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-80) On allocation. Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-50) On allocation. Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-75) On allocation. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 02/22/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-15) Available
Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-80) Available
Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-50) Available
Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-75) Available
Amoxicillin, Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-15) Available
Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-80) Available
Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-50) Available
Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-75) Available
Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-01) Available
Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-01) Available
Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-01) Available
Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-01) Available

Sandoz Inc. (Reverified 02/06/2024)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-46) Available
Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-55) Available
Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-58) Available
Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-46) Available
Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-52) Limited Availability Other Other
Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-57) Limited Availability Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-46) Limited Availability Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-52) Limited Availability Demand increase for the drug
Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-57) Limited Availability Demand increase for the drug
Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-46) Limited Availability Demand increase for the drug
Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-55) Available
Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-58) Limited Availability Demand increase for the drug

Teva Pharmaceuticals USA, Inc. (Revised 02/06/2024)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-73) Allocating existing supply
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-80) Allocating existing supply Demand increase for the drug
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-79) Allocating existing supply
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-73) Allocating existing supply
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-76) Allocating existing supply
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-78) Limited Availability, Estimated recovery Feb 2024 Demand increase for the drug
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-73) Unavailable, Estimated Recovery May 2024 Demand increase for the drug
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-76) Allocating existing supply
Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-78) Allocating existing supply, Estimated Recovery Dec 2024 Demand increase for the drug
Back to Top